{"nct_id":"NCT01084252","title":"Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies","status":"COMPLETED","status_verified_date":"2024-10","start_date":"2010-05-11","start_date_type":"ACTUAL","primary_completion_date":"2018-12-21","primary_completion_date_type":"ACTUAL","completion_date":"2023-07-13","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["SNY"]}